Production and regulatory issues for theranostics - 29/05/24
Doi : 10.1016/S1470-2045(24)00041-X
Francesco Giammarile, ProfMD PhD a, Diana Paez, MD a, Richard Zimmermann, PhD d, e, f, Cathy S Cutler, ProfPhD g, Amirreza Jalilian, ProfPhD b, Aruna Korde, PhD b, Peter Knoll, PhD b, Nayyereh Ayati, PhD h, Jason S Lewis, ProfPhD i, j, Suzanne E Lapi, ProfPhD k, Roberto C Delgado Bolton, ProfMD PhD l, m, Jolanta Kunikowska, ProfMD n, Enrique Estrada Lobato, MD a, Jean-Luc Urbain, MD o, Ola Holmberg, PhD c, May Abdel-Wahab, ProfMD PhD a, Andrew M Scott, ProfMD p, q, r, s, ⁎ 
a Division of Human Health, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria
b Division of Physical and Chemical Sciences, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria
c Department of Nuclear Science and Applications, and Division of Radiation, Transport and Waste Safety, Department of Nuclear Safety and Security, International Atomic Energy Agency, Vienna, Austria
d Chrysalium Consulting, Lalaye, France
e MEDraysintell, Louvain la Neuve, Belgium
f Oncidium Foundation, Auderghem, Belgium
g Isotope Research and Production Department, Brookhaven National Laboratory Upton, New York City, NY, USA
h Centre for Health Economics, Monash Business School, Monash University, Melbourne, VIC, Australia
i Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, Upton, NY, USA
j Departments of Radiology and Pharmacology, Weill Cornell Medical College, New York City, NY, USA
k Departments of Radiology and Chemistry, O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
l Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja, Logroño, Spain
m Servico Cántabro de Salud, Santander, Spain
n Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland
o Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
p Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia
q Department of Molecular Imaging and Therapy, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia
r School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia
s Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia
* Correspondence to: Prof Andrew M Scott, Department of Molecular Imaging and Therapy, Olivia Newton-John Cancer Research Institute, Melbourne, VIC 3084, Australia Department of Molecular Imaging and Therapy Olivia Newton-John Cancer Research Institute Melbourne VIC 3084 Australia
Summary |
Theranostics has become a major area of innovation and progress in cancer care over the last decade. In view of the introduction of approved therapeutics in neuroendocrine tumours and prostate cancer in the last 10 years, the ability to provide access to these treatments has emerged as a key factor in ensuring global benefits from this cancer therapy approach. In this Series paper we explore the issues that affect access to and availability of theranostic radiopharmaceuticals, including supply and regulatory issues that might affect the availability of theranostic treatments for patients with cancer.
Le texte complet de cet article est disponible en PDF.Plan
© 2024
Elsevier Ltd. Tous droits réservés.
Vol 25 - N° 6
P. e260-e269 - juin 2024 Retour au numéro
Article précédent
- Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics
- Andrew M Scott, Brian M Zeglis, Suzanne E Lapi, Peter J H Scott, Albert D Windhorst, May Abdel-Wahab, Francesco Giammarile, Diana Paez, Amirreza Jalilian, Peter Knoll, Aruna Korde, Shrikant Vichare, Nayyereh Ayati, Sze Ting Lee, Serge K Lyashchenko, Jingjing Zhang, Jean Luc Urbain, Jason S Lewis
- Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities
- May Abdel-Wahab, C Norman Coleman, Jesper Grau Eriksen, Peter Lee, Ryan Kraus, Ekaterina Harsdorf, Becky Lee, Adam Dicker, Ezra Hahn, Jai Prakash Agarwal, Pataje G S Prasanna, Michael MacManus, Paul Keall, Nina A Mayr, Barbara Alicja Jereczek-Fossa, Francesco Giammarile, In Ah Kim, Ajay Aggarwal, Grant Lewison, Jiade J Lu, Douglas Guedes de Castro, Feng-Ming (Spring) Kong, Haidy Afifi, Hamish Sharp, Verna Vanderpuye, Tajudeen Olasinde, Fadi Atrash, Luc Goethals, Benjamin W Corn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?